Start treating myopia today!
Optometrist and parent, Dr. Hannah Yecheskel calls MiSight® 1 day the “answer” to her 8-year old daughter’s rapidly progressing myopia.
Learn about MiSight® 1 day for myopia control
Watch the MiSight 15-Minute QuickStart Video to get started today.
Get Started Today!
Dual-benefit of
MiSight® 1 day:
CORRECTS BLURRY DISTANCE VISION
Children wearing MiSight® 1 day achieved better than 20/20 vision across all visits over a 6-year period.*1,2
+
HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION
On average, age-appropriate children wearing MiSight® 1 day progressed less than -1.00D over 6 years.‡3
MiSight® 1 day myopia control soft contact lenses are the first FDA-approved* product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment.†1
Learn More
Take a look at how ActivControl® Technology helps reduce the rate of myopia progression in children by 59% on average.†1
Watch Video
Evidence-based medicine: See the results of the 7-year international study demonstrating a strong safety profile.*†1-4
Learn MoreMyopia management is the standard of care
We can no longer let myopia get worse. Treat this disease seriously – your professional associations have spoken.5
MiSight® 1 day Resources
Make Children's SightYour Fight™.
Indications and Important Safety Information.
Rx only.
Results may vary.
ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information.
* Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8- 12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
† Compared to a single vision 1 day lens over a 3-year period.
‡ Fitted at 8-12 years of age at initiation of treatment.
References:
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
2. Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6- year findings. Optom Vis Sci 2020;97(Eabstract): 200038.
3. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7-year findings. Optom Vis Sci 2021;98 (Eabstract): 210049.
4. Woods, J., Jones, D., Jones, L., Jones, S., Hunt, C., Chamberlain, P., & McNally, J. (2021). Ocular health of children wearing daily disposable contact lenses over a 6-year period. Contact Lens and Anterior Eye.
5. Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopiamanagement-byoptometrists.
MiSight® 1 day is a registered trademark of The Cooper Companies, Inc. and its subsidiaries.